In 2014, Wheeler et al. was a leader in reporting specifically on cancer pharmacogenomics, delineating evidence for gene-drug relationships including genes TMPT, UGT1A1, CYP2D6, and SLC O 1B1. The gene discussed is CYP2D6; the disease is cancer.